ACT Capital Partners, L.P.’s Kura Oncology KURA Stock Holding History

ACT Capital Partners, L.P.’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$981K	Buy	+91,600	New	+$1.02M	0.64%	30

Other funds holding KURA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

ACT Capital Partners, L.P.'s KURA Position: Q3 2026 in Review

ACT Capital Partners, L.P. opened a new position in Kura Oncology (KURA) in Q3 2026: 91,600 shares worth $981K. The stake represents 0.64% of the portfolio and ranks #30 among its holdings.

84 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

ACT Capital Partners, L.P. held 91,600 shares of Kura Oncology worth $981K as of Q3 2026.
Kura Oncology was a new ACT Capital Partners, L.P. position in Q3 2026.
Kura Oncology made up 0.64% of ACT Capital Partners, L.P.'s portfolio in Q3 2026, its #30 holding.
84 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on ACT Capital Partners, L.P.'s 13F filing for Q3 2026, filed 6 Nov 2026.